Tower Research Capital (TRC)’s Guardian Pharmacy Services GRDN Stock Holding History
Bought
Maintained
Sold
Other funds holding GRDN
Tower Research Capital (TRC)'s GRDN Position: Q3 2026 in Review
Tower Research Capital (TRC) reduced its Guardian Pharmacy Services (GRDN) stake by 31% in Q3 2026, selling an estimated $24.6K and leaving 1,329 shares worth $54.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3177.
Tower Research Capital (TRC) first reported a position in GRDN in Q4 2024 and has held it in 8 quarters since. The position peaked at $80.9K in Q2 2026. 197 funds tracked by Wall St. Rank hold GRDN as of Q3 2026.
- Tower Research Capital (TRC) held 1,329 shares of Guardian Pharmacy Services worth $54.2K as of Q3 2026.
- Tower Research Capital (TRC) sold 603 Guardian Pharmacy Services shares in Q3 2026, an estimated $24.6K.
- Guardian Pharmacy Services made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q3 2026, its #3177 holding.
- Tower Research Capital (TRC) first reported a position in Guardian Pharmacy Services in Q4 2024 and has held it in 8 quarters since.
- Tower Research Capital (TRC)'s Guardian Pharmacy Services position peaked at $80.9K in Q2 2026.
- 197 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q3 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q3 2026, filed 16 Nov 2026.